Heska Corp. (HSKA) Earns Neutral Rating from B. Riley


's stock had its "neutral" rating reissued by equities research analysts at B. Riley in a research report issued to clients and investors on Monday. They presently have a $55.50 price objective on the stock.



from Biotech News